The arterial vasculature is the second most frequently calcified structure in the human body after the skeleton. Calcification of the aorta and aortic valves occurs in most individuals in westernized ...

Highest ever full year total revenues: $255.6 million in 2025, up from $245.0 million in 2024.Adjusted total revenues of $255.5 million in 2025, from $247.6 million in 2024.Record quarter for total ...

WASHINGTON and DALLAS, March 13, 2026 /PRNewswire/ -- The American College of Cardiology (ACC), the American Heart Association and nine other leading medical associations, today issued an updated ...

FY25 EPS of $0.08; FY25 Adjusted EPS growth of 5% to $0.83 YoY Increase in Cash Flow from Operations of $148 million; Free Cash Flow more than doubled to $187 million FY25 YoY Revenue Growth of 2%; ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...

Q4 Revenue Grew 27% Year-Over-Year to Record $14.5 Million Q4 Operating Income of $1.9 Million; Adjusted EBITDA Increased by 53% to $2.3 Million, Reflecting Significant Operating Leverage Full Year ...

Reported Promising Data for TN-201 and TN-401 Gene Therapies in Fourth Quarter of 2025; Additional Data Readouts and Pursuit of Regulatory ...

A comparative evaluation indicates that climate anomalies over the past three years have been particularly severe. The rise in temperatures in certain regions, alongside unprecedented climate ...

Revised 3.2. Measurement of TC, LDL-C, HDL-C, TG, and Non–HDL-C COR 2a: For adults with an LDL-C level <70 mg/dL (<1.8 mmol/L), measurement of direct LDL-C or modified LDL-C estimate is reasonable to ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...

Quantum BioPharma Ltd. (FRA: 0K91) ("Quantum BioPharma" or the "Company"), announces that further to its news release on March 10, 2026 (the "March 10 NR"), due to a decrease in the public market ...